hotspot -WSS

hotspot

author：entertainment 2025-10-01 00:59:45 - browse：5292

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Choosing scientific sides in the fight against Alzheimer's

WSS

FDA does about

Biden praises World Series champion Astros for impact off the field during White House celebration

In venture capital firm's success, lessons for turning crisis into profit

Ohioans vote in high

Germany receives 178 compensation applications from gay servicepeople over discrimination

RSV vaccines may be linked to small increased risk of developing GBS

knowledge

hotspot

knowledge

Medicare details structure of new drug price negotiation program

Former Georgia lieutenant governor says he received grand jury subpoena

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Kenai launches with $82 million for Parkinson’s stem cell therapy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Change Healthcare cyberattack outage could last weeks

Guidelines to prevent youth baseball injuries need more muscle

Hospitals use virtual reality to design more inclusive rooms for kids

The cancer drug shortage isn’t new — and neither are the solutions

Congress gives doctors Medicare pay bump

focus

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Zapping the brain for stroke rehab: Pivotal clinical trial begins

In venture capital firm's success, lessons for turning crisis into profit

CDC launches VaccineFinder tool to locate Covid

Medical device lobby: We're tired of waiting on Medicare coverage

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

entertainment

leisure time

explore

focus